NTI receives SBIR grant funding from the NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to develop an innovative test for early diagnosis of Systemic Lupus Erythematosus (SLE), an autoimmune disease in which the body's immune system mistakenly attacks healthy tissue, implementing a panel of microRNA and autoantibody biomarkers and overcoming limitations of current SLE testing.

NTI receives SBIR grant funding from the NIH/National Institute on Aging (NIA) to develop a multiplexed protein and microRNA biomarker-based next-generation test for Alzheimers Disease (AD), expected to improve early disease detection and implementation of optimized patient management strategies.

NTI receives SBIR grant funding from the NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to develop a multiplex protein and microRNA biomarker-based test for protease activity profiling in arthritic joints which should prove highly useful for drug development and personalized treatments.

A team of researchers, including NTI's Principal Scientist Dr. Taiho Kim, publishes its break-through discovery in the prestigious journal Science, obtained using an advanced ALEX spectroscopy intrumentiation established by NTI. (Chakraborty, A., Wang, D., Ebright, Y.W., Korlann, Y., Kortkhonjia, E., Kim, T., Chowdhury, S., Wigneshweraraj, S., Irschik, H., Jansen, R., Nixon, B.T., Knight, J., Weiss, S. & Ebright, R.H. Opening and Closing of the Bacterial RNA Polymerase clamp. Science, 337, 591-595 (2012))